+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infection Control Market Size, Share & Trends Analysis Report By Type (Equipment, Services, Consumables), By End Use (Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, Others), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • July 2025
  • Region: Global
  • Grand View Research
  • ID: 6154706
REQUEST CUSTOMIZATION
Description Jump to:
The global infection control market size was estimated at USD 52.38 billion in 2024, and is projected to reach USD 74.21 billion by 2030, growing at a CAGR of 6.1% from 2025 to 2030. The market is primarily driven by an increasing number of surgical & clinical procedures that require infection prevention.

Technological advancements in infection control have significantly enhanced the ability of healthcare providers to prevent and manage infections. Innovations such as automated disinfection systems, UV light technology, antimicrobial surface coatings, and advanced air filtration systems have demonstrated efficacy in reducing HAIs by up to 30% and is expected to contribute to the market growth. An increase in outsourcing sterilization services and the introduction of advanced sterilizing solutions are further contributing to the growth of the market for infection control. One of the important growth drivers is the increasing number of government initiatives to ensure highly intensive infection prevention. Government organizations are increasingly involved in issuing guidelines to promote awareness and efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period. For instance, the World Health Organization (WHO) has issued guidelines for preventing and controlling pandemic- and epidemic-prone acute respiratory diseases in healthcare. The guidelines range from standard precautions such as hand hygiene and usage of personal protective equipment to guidelines for disinfection and sterilization.

According to the article published by the National Library of Medicine in May 2024, Acute respiratory infections (ARIs) are a major global health burden, leading to around 4.25 million deaths annually. These infections lead to millions of outpatient visits each year, particularly affecting high-risk groups such as the elderly, young children, and individuals with chronic conditions such as asthma or heart disease.

Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, and MRSA constitute most hospital-acquired infections. Other major healthcare-associated infections (HAIs) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstream. One of the utmost concerns for the market is HAIs, which affect patient recovery; thereby, mortality rates are being significantly impacted globally. According to an article by NIH in April 2023, HAIs are the most common adverse effects in hospitals, leading to serious health risks, increased morbidity and mortality, and higher costs for patients, families, and healthcare systems. HAIs affect about 3.2% of hospitalized patients in the U.S. and 6.5% in the EU, with global prevalence expected to be even higher. This facilitates the need for effective infection prevention and control solutions.

According to a practical guide published by the WHO on preventing hospital-acquired infections, the increase in hospitalization duration with surgical infections was approximately eight days. These prolonged stays are predicted to significantly contribute to the overall costs incurred during the hospitalization period, thus, raising the clinical urgency for adopting infection prevention measures. It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers due to excessive usage of resources to treat the acquired infection. These additional costs are majorly generated through increased usage of drugs, additional diagnostic studies, and laboratory equipment, creating a resource allocation imbalance.

Global Infection Control Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, the analyst has segmented the global infection control market on the basis of type, end use, and region:

Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Equipment
  • Disinfectors
  • Washers
  • Flushes
  • Endoscope Reprocessors
  • Sterilization Equipment
  • Heat Sterilization Equipment
  • Low Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Filtration Sterilization Equipment
  • Liquid Sterilization Equipment
  • Others
  • Services
  • Contract Sterilization
  • Ethylene Oxide Sterilization
  • E-beam Sterilization
  • Gamma Sterilization
  • Others
  • Infectious Waste Disposal
  • Consumables
  • Infectious Waste Disposal
  • Disinfectants
  • Sterilization Consumables
  • Safety enhanced medical devices
  • Personal Protective Equipment
  • Others

End Use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Laboratories
  • Others

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Infection Control Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Infection Control Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Infection Control Market: Pipeline Analysis
Chapter 4. Infection Control Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. Infection Control Market: Type Movement Analysis
4.3. Global Infection Control Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Equipment
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Disinfectors
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Washers
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Flushes
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.4. Endoscope Reprocessors
4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Sterilization Equipment
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.2. Heat sterilization equipment
4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. Low Temperature Sterilization Equipment
4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.4. Radiation Sterilization Equipment
4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.5. Filtration Sterilization Equipment
4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.6. Liquid Sterilization Equipment
4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Services
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Contract Sterilization
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. Ethylene Oxide Sterilization
4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. E-beam Sterilization
4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.4. Gamma Sterilization
4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.5. Others
4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Infectious Waste Disposal
4.6. Consumables
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Infectious Waste Disposal
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Disinfectants
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Sterilization Consumables
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Personal Protective Equipment
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.6. Others
4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Infection Control Market: End Use Estimates & Trend Analysis
5.1. End Use Segment Dashboard
5.2. Infection Control Market: End Use Movement Analysis
5.3. Global Infection Control Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Medical Device Companies
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Clinical Laboratories
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Pharmaceutical Laboratories
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Infection Control Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Infection Control Market by Region: Key Takeaways
6.4. North America
6.4.1. U.S.
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. UK
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Norway
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Argentina
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/ reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. 3M
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Belimed AG
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. O&M Halyard or its affiliates.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. GETINGE AB (publ) Corporate
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. ASP
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. MATACHANA
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Sterigenics U.S., LLC - A Sotera Health company
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. MMM Group
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Medivators Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. STERIS.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Midmark Corporation.
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. W&H
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global infection control market, by region, 2018 - 2030 (USD Million)
Table 3 Global infection control market, by type, 2018 - 2030 (USD Million)
Table 4 Global infection control market, by end use, 2018 - 2030 (USD Million)
Table 5 North America infection control market, by country, 2018 - 2030 (USD Million)
Table 6 North America infection control market, by type, 2018 - 2030 (USD Million)
Table 7 North America infection control market, by end use, 2018 - 2030 (USD Million)
Table 8 U.S. infection control market, by type, 2018 - 2030 (USD Million)
Table 9 U.S. infection control market, by end use, 2018 - 2030 (USD Million)
Table 10 Canada infection control market, by type, 2018 - 2030 (USD Million)
Table 11 Canada infection control market, by end use, 2018 - 2030 (USD Million)
Table 12 Mexico infection control market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico infection control market, by end use, 2018 - 2030 (USD Million)
Table 14 Europe infection control market, by country, 2018 - 2030 (USD Million)
Table 15 Europe infection control market, by type, 2018 - 2030 (USD Million)
Table 16 Europe infection control market, by end use, 2018 - 2030 (USD Million)
Table 17 Germany infection control market, by type, 2018 - 2030 (USD Million)
Table 18 Germany infection control market, by end use, 2018 - 2030 (USD Million)
Table 19 UK infection control market, by type, 2018 - 2030 (USD Million)
Table 20 UK infection control market, by end use, 2018 - 2030 (USD Million)
Table 21 France infection control market, by type, 2018 - 2030 (USD Million)
Table 22 France infection control market, by end use, 2018 - 2030 (USD Million)
Table 23 Italy infection control market, by type, 2018 - 2030 (USD Million)
Table 24 Italy infection control market, by end use, 2018 - 2030 (USD Million)
Table 25 Spain infection control market, by type, 2018 - 2030 (USD Million)
Table 26 Spain infection control market, by end use, 2018 - 2030 (USD Million)
Table 27 Denmark infection control market, by type, 2018 - 2030 (USD Million)
Table 28 Denmark infection control market, by end use, 2018 - 2030 (USD Million)
Table 29 Sweden infection control market, by type, 2018 - 2030 (USD Million)
Table 30 Sweden infection control market, by end use, 2018 - 2030 (USD Million)
Table 31 Norway infection control market, by type, 2018 - 2030 (USD Million)
Table 32 Norway infection control market, by end use, 2018 - 2030 (USD Million)
Table 33 Asia Pacific infection control market, by country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific infection control market, by type, 2018 - 2030 (USD Million)
Table 35 Asia Pacific infection control market, by end use, 2018 - 2030 (USD Million)
Table 36 China infection control market, by type, 2018 - 2030 (USD Million)
Table 37 China infection control market, by end use, 2018 - 2030 (USD Million)
Table 38 Japan infection control market, by type, 2018 - 2030 (USD Million)
Table 39 Japan infection control market, by end use, 2018 - 2030 (USD Million)
Table 40 India infection control market, by type, 2018 - 2030 (USD Million)
Table 41 India infection control market, by end use, 2018 - 2030 (USD Million)
Table 42 South Korea infection control market, by type, 2018 - 2030 (USD Million)
Table 43 Australia infection control market, by type, 2018 - 2030 (USD Million)
Table 44 Thailand infection control market, by type, 2018 - 2030 (USD Million)
Table 45 Thailand infection control market, by end use, 2018 - 2030 (USD Million)
Table 46 Latin America infection control market, by country, 2018 - 2030 (USD Million)
Table 47 Latin America infection control market, by type, 2018 - 2030 (USD Million)
Table 48 Latin America infection control market, by end use, 2018 - 2030 (USD Million)
Table 49 Brazil infection control market, by type, 2018 - 2030 (USD Million)
Table 50 Brazil infection control market, by end use, 2018 - 2030 (USD Million)
Table 51 Argentina infection control market, by type, 2018 - 2030 (USD Million)
Table 52 Argentina infection control market, by end use, 2018 - 2030 (USD Million)
Table 53 MEA infection control market, by country, 2018 - 2030 (USD Million)
Table 54 MEA infection control market, by type, 2018 - 2030 (USD Million)
Table 55 MEA infection control market, by end use, 2018 - 2030 (USD Million)
Table 56 South Africa infection control market, by type, 2018 - 2030 (USD Million)
Table 57 South Africa infection control market, by end use, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia infection control market, by type, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia infection control market, by end use, 2018 - 2030 (USD Million)
Table 60 UAE infection control market, by type, 2018 - 2030 (USD Million)
Table 61 UAE infection control market, by end use, 2018 - 2030 (USD Million)
Table 62 Kuwait infection control market, by type, 2018 - 2030 (USD Million)
Table 63 Kuwait infection control market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Infection control market: market outlook
Fig. 10 Infection control market competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Infection control market driver impact
Fig. 16 Infection control market restraint impact
Fig. 17 Infection control market strategic initiatives analysis
Fig. 18 Infection control market: Type movement analysis
Fig. 19 Infection control market: Type outlook and key takeaways
Fig. 20 Equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Disinfectors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Washers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Flushes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Endoscope reprocessors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Heat sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Low temperature sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Radiation sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Filtration sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Liquid sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Contract sterilization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Ethylene oxide Sterilization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 E-beam sterilization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Gamma sterilization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Infectious waste Disposal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Infectious waste disposal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Disinfectants market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Safety enhanced medical devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Sterilization consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Personal protective equipment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Infection control market: End use movement Analysis
Fig. 47 Infection control market: End use outlook and key takeaways
Fig. 48 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Pharmaceutical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Global infection control market: Regional movement analysis
Fig. 54 Global infection control market: Regional outlook and key takeaways
Fig. 55 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • 3M
  • Belimed AG
  • O&M Halyard or its affiliates.
  • GETINGE AB (publ) Corporate
  • ASP
  • MATACHANA
  • Sterigenics U.S., LLC - A Sotera Health company
  • MMM Group
  • Medivators Inc.
  • STERIS.
  • Midmark Corporation.
  • W&H

Related Topics

Related Reports

CSSD Infection Control Cleaning Consumables Market - Global Forecast 2025-2030 - Product Image

CSSD Infection Control Cleaning Consumables Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Dental Infection Control Products - Global Strategic Business Report - Product Image

Dental Infection Control Products - Global Strategic Business Report

  • Report
  • 460 Pages
  • Global
From
Infection Control Market Report by Type, End User, and Region 2025-2033 - Product Image

Infection Control Market Report by Type, End User, and Region 2025-2033

  • Report
  • 121 Pages
  • Global
From
Hospital-Acquired Infection Control Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Hospital-Acquired Infection Control Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Hospital Acquired Infection Control - Global Strategic Business Report - Product Image

Hospital Acquired Infection Control - Global Strategic Business Report

  • Report
  • 246 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.